The actual GHK-Cu content, as verified by laboratory testing, is 16%
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Reestablishing the cellular metabolic homeostasis in inflammatory diseases as well as SARS-CoV-2 infection and COVID-19 disease especially in the lungs and cardiovascular system, could become paramount to balance altered innate and adaptive immunity and cell function and reduce morbimortality (333335)
Applied topical GHK-Cu solution to scalp three nights per week as a complement
Alpha lipoic acid (ALA) is an organosulfur fatty acid with with antioxidative properties * Nutrient Reference Value according to Regulation (EU) 1169/2011 ** No reference value available You are currently viewing a placeholder content from Facebook
Mistakes here compound throughout the entire vial
